EvidenceStrategy&OperationLead

**Job Purpose** At GSK, we are uniting science, technology, and talent to get ahead of disease together. The Evidence Generation Strategy & Operations Lead is responsible to provide DGP process coordination and study/ project management, statistic & data management expertise for studies in Japan CPO to ensure the delivery of evidence generation to support launch readiness, pricing, reimbursement and life cycle management. The role will also partner closely with the Japan Head of RWE-HO to ensure timely planning and tracking for enterprise strategic and capability building initiatives, ensuring excellence of teams. **Key Responsibilities** Reporting directly to the Japan Head of Real-World Evidence & Health Outcomes, the role will: • Shape evidence-generation strategy across therapeutic areas and drive cross-portfolio operational synergies. • Acts as leader to enterprise evidence strategy and operations, covering aspects of evidence synthesis, analytics and study operations to provide coaching and implement internal standards and processes. • Responsible for the timing and quality delivery of the study/ projects and organize the regular study monitor meeting for dashboard management. • Ensures study quality standards, i.e. no significant compliance (GCP, SOP or applicable regulations) issue throughout study planning and execution. • Redefine processes and ways of working to enable more efficient and effective planning and execution of data-generation programs, standardizing workflows, reducing duplication and accelerating delivery across the portfolio. • Responsible for the quality of outsource service through vendor management. • Maintains effective communication with internal and external stakeholders. • Proactively identify and drive cross-TA and cross-portfolio synergies (e.g., data reuse, harmonized study designs, shared analytics) to increase efficiency, reduce duplication and accelerate timelines. • Represents Japan RWE-HO in cross-regional forums on evidence